Genetic products differentially expressed in tumors and the use thereof

Details for Australian Patent Application No. 2003282101 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Tureci, Ozlem; Sahin, Ugur; Koslowski, Michael

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003282101

PCT Number PCT/EP2003/0130

PCT Pub. Number WO2004/047863

Priority 102 54 601.0 22.11.02 DE

Filing date 21 November 2003

Wipo publication date 18 June 2004

Acceptance publication date 11 March 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): 102 54 601.0 22.11.02 DE

22 July 2004 Application Open to Public Inspection

  Published as AU-B-2003282101

11 March 2010 Application Accepted

  Published as AU-B-2003282101

8 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003282102-BIVENTRICULAR CARDIAC PACEMAKER FOR CARDIAC RESYNCHRONISATION THERAPY

2003282100-PROCESS FOR DISSOLVING LIPOPHILIC COMPOUNDS IN AQUEOUS SOLUTION WITH AMPHIPHILIC BLOCK COPOLYMERS, AND COSMETIC COMPOSITION